AI주식인사이트AI Stock Insight
C

지엘팜텍

204840KOSDAQ생활용품 도매업

42.9 / 100

Reference Date: 2026-06-10

Financial Score9.5 / 40
News Sentiment19.4 / 25
Momentum4.0 / 20
Disclosure10.0 / 15
AI Analysis: ROE is above the industry average but the high debt ratio poses financial risk. Declined 8.5% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

GELPAMTEK primarily operates in pharmaceutical R&D services and has expanded into drug distribution and marketing. Its subsidiary, GELPHARMA, focuses on pharmaceutical manufacturing and sales, with key products including gastritis treatments, neuropathic pain medications, and specialty drugs. The company also generates revenue through technology fees and royalties from licensing its improved new drug technologies.

Number of Employees

32people

Average Salary

46.5M KRW

Score Calculation Basis

Detailed Financial Score

PER
5625.62Industry Average 10.950.0Point

513.8x industry avg (risky)

PBR
3.53Industry Average 0.660.0Point

5.3x industry avg (risky)

ROE
0.06Industry Average 0.064.0Point

In line with industry avg

Debt Ratio
37.41Industry Average 11.050.0Point

3.4x industry avg (risky)

Trend 2023~20255.5 / 10 points
Revenue Growth Rate
2.5 / 3

Avg ▲17.7% (2-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲80.2% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -13.7% (improving, 3yr)

Detailed News Sentiment

4 totalPositive 3Neutral 1Negative 0Average Sentiment Score 77.5

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 906Won52-week high 1,31552-week low 906
1-month return1.0Point

1m -8.48% (falling)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

8 totalPositive 0Neutral 8Negative 0
  • Neutral[첨부정정]주요사항보고서(회사합병결정)2026-06-01
  • Neutral[첨부정정]주요사항보고서(회사합병결정)2026-05-28
  • Neutral주주명부폐쇄기간또는기준일설정2026-05-28
  • Neutral주요사항보고서(회사합병결정)2026-05-28
  • Neutral주주명부폐쇄기간또는기준일설정2026-05-19